Agenda of the webinar:

Speaker: Doctor Nuria Monserrat

Title: iPS-derived cardiac myocytes in cardiac repair

Speaker: Professor Wolframm Zimmermann

Title: Engineered Human Myocardium: from preclinical development to “first in man”

Needs assessment and expected educational outcome:

To update the scientific community about pluripotent stem cell-based approaches that may revolutionise the treatment of advanced heart failure, as well as current standard-of-care and clinical practice guidelines. Advanced heart failure lacks definitive treatment except for heart transplantation, which has well-known complications, including primary graft failure and chronic transplant vasculopathy. Therefore, new therapies need to be developed to improve the quality of life and survival of patients with advanced cardiovascular disease.

Learning objectives

After watching this webinar, participants will be able to:

- know the latest advances with iPSC technologies in cardiovascular reparative medicine;

- discuss optimal translational strategies to achieve meaningful results in clinical trials; and

- anticipate future pluripotent stem cell-based approaches in the field of cardiovascular reparative medicine.

ESC 365 is supported by